⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL143927 | 1.00 | — | — | |
| SCHEMBL143928 | 1.00 | — | — | |
| SCHEMBL607966 | 1.00 | ANPEP (0.52) | — | |
| SCHEMBL27950660 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL7062675 | 0.97 | — | — | |
| SCHEMBL27960957 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL7062673 | 0.97 | — | — | |
| SCHEMBL27950659 | 0.97 | — | — | |
| SCHEMBL27960955 | 0.97 | — | — | |
| L-Alaninol SCHEMBL3407773 | 0.94 | TSHR (0.50) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 530 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025019172-A1 | ANTIMICROBIAL EXTRACTANT FORMED FROM COPPER-CONTAINING SOURCE | CORNING INCORPORATED (US) | 2025-01-23 | — | — | WO | claimed |
| CN-116514896-B | Synthesis method of dihydrotanshinone I | 浙江大学 | 2024-10-01 | — | — | CN | claimed |
| CN-117165542-A | Engineered beta-amino alcohol dehydrogenase and its use in chiral (R) -beta-amino alcohol preparation | 中山大学 | 2023-12-05 | — | — | CN | claimed |
| CN-117126896-A | Method for preparing (R) -beta-amino alcohol by racemization removal through biological enzyme method | 中山大学 | 2023-11-28 | — | — | CN | claimed |
| CN-116514896-A | Synthesis method of dihydrotanshinone I | 浙江大学 | 2023-08-01 | — | — | CN | claimed |
| CN-115304729-A | High-crystallinity chiral two-dimensional covalent organic framework material and preparation method thereof | 中国科学院化学研究所 | 2022-11-08 | — | — | CN | claimed |
| US-8354444-B2 | Substituted pyrrolidine-2-carboxamides | HOFFMANN-LA ROCHE INC. (US) | 2013-01-15 | — | — | US | claimed |
| EP-2340021-B1 | SUBSTITUTED PYRROLIDINE-2-CARBOXAMIDES | HOFFMANN LA ROCHE (CH) | 2012-11-07 | — | — | EP | claimed |
| US-8188093-B2 | Pyrazinecarboxamide derivatives as HDL-cholesterol raising agents | HOFFMANN-LA ROCHE INC. (US) | 2012-05-29 | — | — | US | claimed |
| EP-2450350-A1 | 3-Pyridinecarboxamide and 2-pyrazinecarboxamide derivatives as HDL-cholesterol raising agents | F. Hoffmann-La Roche AG (CH) | 2012-05-09 | — | — | EP | claimed |
| CN-102159207-A | Substituted pyrrolidine-2-carboxamides | HOFFMANN LA ROCHE | 2011-08-17 | — | — | CN | claimed |
| US-20100267745-A1 | 3-Pyridinecarboxamide Derivatives as HDL-Cholesterol Raising Agents | ANDJELKOVIC MIRJANA | 2010-10-21 | — | — | US | claimed |
| US-20100152190-A1 | Substituted Pyrrolidine-2-Carboxamides | F. HOFFMANN-LA ROCHE AG (CH) | 2010-06-17 | — | — | US | claimed |
| US-20100075948-A1 | Substituted Pyrrolidine-2-Carboxamides | DING QINGJIE | 2010-03-25 | — | — | US | claimed |
| EP-2074096-A1 | 3-PYRIDINECARBOXAMIDE AND 2-PYRAZINECARBOXAMIDE DERIVATIVES AS HDL-CHOLESTEROL RAISING AGENTS | F.HOFFMANN-LA ROCHE AG (CH) | 2009-07-01 | — | — | EP | claimed |
| WO-2008040651-A1 | 3-PYRIDINECARBOXAMIDE AND 2-PYRAZINECARBOXAMIDE DERIVATIVES AS HDL-CHOLESTEROL RAISING AGENTS | F. HOFFMANN-LA ROCHE AG (CH) | 2008-04-10 | — | — | WO | claimed |
| US-20080085906-A1 | 3-Pyridinecarboxamide derivatives as HDL-cholesterol raising agents | F. HOFFMANN-LA ROCHE AG (CH) | 2008-04-10 | — | — | US | claimed |
| CN-1100100-A | 1-beta-methy1-2-thiolic carbapenem derivatives | DONG KOOK PHARM CO LTD (KR) | 1995-03-15 | — | — | CN | claimed |
| US-12509434-B2 | Optically resolved Trolox intermediate and method for producing same | PTC THERAPEUTICS, INC. (US) | 2025-12-30 | — | — | US | disclosed |
| EP-0590793-A1 | Oxazolidine derivatives having anti-diabetic and anti-obesity properties, their preparation and their therapeutic uses | SANKYO COMPANY LIMITED (JP) | 1994-04-06 | — | — | EP | disclosed |